Updated Jun 2, 2026
Selected portfolio
Experimental
Top 1 · Quarterly · Equal
Rank #6
Risk
Experimental
Risk
Experimental
Stocks included
Top 1
Stocks included
Top 1
Rebalance
Quarterly
Rebalance
Quarterly
Weighting
Equal weight
Weighting
Equal weight
Key metrics
Since Feb 17, 2026
- $15,196 (+52.0%)
Portfolio value
- +40.8%
Performance vs S&P 500
- 3.07
Sharpe ratio
- +328.7%
CAGR
- -19.5%
Max drawdown
What you are looking at
Starting capital: $10,000 simulated. Disclaimer
| # | Stock | Value | Cost basis |
|---|---|---|---|
Returns
Risk
Consistency
Want the methodology notes?
See the full methodology, portfolio-ranking rules, and scientific grounding.
Not investment advice. Past performance does not guarantee future results. Full disclaimer